The Economic Times

Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over superpotent medicine check lot number, expiration date and what patients should know

Vitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tablets after the medicine was found to be potentially superpotent. The recalled Thyroid Tablets, USP 30 mg may contain more thyroid hormone than intended, raising concerns about serious health effects. Patients currently taking Thyroid, USP from Lot 504950 should contact their healthcare provider.